SES AI Corporation [SES] Securities Class Action Lawsuit Update

• Case Name: Patel v. SES AI Corporation, et al.
• Case No.: 1:26-cv-11894-NMG
• Jurisdiction: United States District Court, District of Massachusetts
• Filed on: April 27, 2026
• Class Period: January 29, 2025 – March 4, 2026

Introduction

SES AI Corporation told investors it was building the future of battery technology, AI-enhanced lithium-metal batteries, next-generation energy storage systems, and a platform called “Molecular Universe” that the company said could accelerate battery-material discovery.

A newly filed securities class action claims SES AI and CEO Qichao Hu misled shareholders by overstating the value of partnerships, exaggerating commercialization prospects, and presenting counterparties as meaningful revenue drivers when those entities allegedly had limited operations or little ability to execute. The complaint also alleges SES created the appearance of revenue through reciprocal transactions tied to its Molecular Universe platform and failed to disclose logistics constraints that materially affected fourth-quarter 2025 revenue.

The final break came in March 2026, when the company disclosed delayed shipments, weaker-than-expected 2026 revenue guidance, and a slower commercialization path than investors had been led to expect. SES stock fell 36.8% in a single trading day.

This is where securities litigation begins: not with volatility, but with the allegation that investors were sold confidence instead of clarity.

“Most SES shareholders never file or join the class action, which means they miss out on potential recovery funds,” said Attorney Joseph Levi.

Backdrop and Business Context

SES AI Corporation positions itself as a developer and manufacturer of high-performance, AI-enhanced lithium-metal and lithium-ion rechargeable battery technologies for energy storage systems, urban air mobility, drones, robotics, EVs, and related applications. The company describes its mission as accelerating the global energy transition through material discovery and battery management. Its strategy relies heavily on combining battery science with artificial intelligence, from cell design to battery safety monitoring.

The company trades on the New York Stock Exchange under the ticker symbol SES and is headquartered in Woburn, Massachusetts. CEO and Chairman Qichao Hu, the company’s founder, is the central executive named in the complaint.

According to allegations cited in the complaint, by 2025 SES was attempting to reposition itself as traditional OEM relationships with major automotive players such as Honda, Hyundai, and GM appeared under pressure, and the company increasingly emphasized Energy Storage Systems, drone batteries, and Molecular Universe as future growth engines.

That pivot mattered. Investors were no longer buying a battery company alone, they were buying a commercialization story.

Promises Made vs. Reality

On January 29, 2025, SES announced a non-binding memorandum of understanding with AISPEX, described as a Texas-based retail energy provider, targeting up to $45 million and up to 100 MWh of advanced Battery Energy Storage System deployment, including an initial project at a crypto mining site in Texas. The company framed the deal as a major new revenue pipeline.

Weeks later, during the February 2025 earnings call, Hu reinforced the message: “This relationship is the first of its kind for SES AI, and we believe that this is something that can be replicated with additional partners in the future.” Investors now allege AISPEX had no meaningful crypto mining operations in Texas and that the MOU materially overstated the likelihood of long-term revenue.

The same pattern appeared with Data Blanket, a drone startup SES described as a “significant purchase order” customer. Plaintiffs allege SES never actually delivered product to Data Blanket and that the company itself was a small startup with only limited operations, making claims of significant business misleading.

SES also acquired UZ Energy and described it as positioning the company to become “an active player in the global $300 billion ESS market.” Investors allege UZ was in reality a low-margin business with minimal U.S. presence and structural concerns around its operations and corporate footprint.

Then came Molecular Universe. SES promoted it as a major AI platform capable of discovering battery materials and generating recurring revenue through software subscriptions and a joint venture with Hisun New Energy Materials. Hu stated: “We expect this JV to provide us with a new source of recurring revenue.”

Plaintiffs allege Hisun had no meaningful U.S. manufacturing capacity and that Molecular Universe revenue may have been artificially created through reciprocal purchasing arrangements rather than genuine demand.

Promises were public. Operational reality, plaintiffs say, was something else.

Timeline of Alleged Misconduct and Disclosures

The alleged misconduct begins on January 29, 2025, with the AISPEX announcement and its projected $45 million opportunity.

In February 2025, SES amplified the message during its Q4 2024 earnings call, highlighting AISPEX and Data Blanket as meaningful commercial wins while emphasizing its AI-first battery strategy.

In September 2025, SES announced the closing of its UZ Energy acquisition, describing it as a major step into the global ESS market. In October 2025, it announced the Hisun joint venture tied to Molecular Universe. Investors were told this would create a recurring revenue stream and accelerate commercialization.

In November 2025, the company filed its Q3 2025 Form 10-Q and included general risk disclosures about reliance on third-party manufacturers. Plaintiffs allege SES already knew material logistics constraints were affecting operations and failed to disclose that those constraints would materially impact Q4 revenue.

On December 9, 2025, Wolfpack Research published a short report attacking the company’s narrative. The report described “phantom deals,” questioned AISPEX’s operations, raised concerns about UZ Energy’s U.S. presence and related-entity connections, and alleged Molecular Universe resembled a “Chat GPT wrapper.” It also quoted a former employee who claimed that “the announcement [of the deal] was a complete surprise and then it was like nobody ever talked about it.”

On March 4, 2026, the company finally disclosed that logistics constraints had delayed shipments and pushed approximately $1.5 million of revenue into Q1 2026. It also issued 2026 revenue guidance of $30 million to $35 million, well below analyst expectations of $51.67 million.

The next day, SES shares fell from $1.71 to $1.08, a 36.8% decline.

Investor Harm and Market Reaction

Loss causation in securities litigation often turns on a simple question: when did the market learn the truth?

For SES investors, plaintiffs point to March 5, 2026.

After the company disclosed delayed shipments and weak 2026 guidance, Benzinga reported that SES shares were “trading sharply lower” after the company’s outlook trailed Wall Street expectations. Analysts had expected $51.67 million in revenue, but SES projected only $30 million to $35 million.

That gap mattered because it challenged the credibility of the company’s commercialization narrative. If ESS, drones, and Molecular Universe were truly positioned for near-term scale, investors argue, the guidance should have reflected it.

Instead, the company acknowledged delayed shipments and slower growth.

The market reacted immediately. SES stock dropped 36.8% in one day, erasing substantial shareholder value and anchoring the damages theory in the complaint.

This is the familiar arc of securities fraud litigation: optimism, repetition, disclosure, repricing.

Litigation and Procedural Posture

The action is styled Patel v. SES AI Corporation, et al. and was filed in the District of Massachusetts on April 27, 2026. Plaintiff Ramesh Patel seeks to represent investors who purchased or otherwise acquired publicly traded SES securities between January 29, 2025 and March 4, 2026.

The complaint asserts claims under Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 against SES AI and CEO Qichao Hu, along with Section 20(a) control person claims against Hu individually.

Scienter allegations focus on repeated statements regarding partnerships, growth prospects, and revenue visibility despite alleged knowledge that counterparties lacked meaningful operations and logistics constraints were already affecting revenue.

Plaintiffs also point to insider sales by Chief Science Officer Dr. Hong Gan, who sold 250,000 shares in November 2025 for $497,500 and another 250,000 shares in January 2026 for $590,000.

The complaint also relies on former-employee statements cited in the Wolfpack report, particularly regarding AISPEX, Data Blanket, and Molecular Universe’s practical value and revenue recognition.

At this stage, these remain allegations, not findings. But the pleading lays out a familiar theory: inflated expectations supported by statements that allegedly lacked a reasonable basis.

SEC Filings & Risk Factors

SES’s SEC filings are central to the complaint because they allegedly gave investors confidence while omitting known operational risks.

In the November 12, 2025 Form 10-Q for the quarter ended September 30, 2025, SES included a risk factor titled: “We depend upon component and product manufacturing and logistical services provided by third parties, many of whom are located outside of the U.S.”

The filing warned that disruptions involving third-party manufacturers could lead to delayed delivery of products, business interruptions, warranty liabilities, revenue loss, and increased costs. It specifically stated that if the company were required to change manufacturers, it could “lose revenue, incur increased costs and damage our end-customer relationships.”

Plaintiffs argue this disclosure was incomplete because SES allegedly already knew it was materially affected by logistics constraints that would impact fourth-quarter revenues. In other words, the risk was not hypothetical, it had already arrived.

The same Form 10-Q also included Sarbanes-Oxley certifications signed by Hu attesting to the accuracy of financial reporting and disclosure of material changes and fraud. Plaintiffs use those certifications to support their theory that management knew or should have known the true operational picture.

That distinction matters. Securities litigation often turns on the difference between warning that something could happen and failing to disclose that it already had.

How to Join the SES AI Corporation (SES) Class Action

• Confirm you purchased SES shares during the January 29, 2025 to March 4, 2026 class period
• Review eligibility details and transaction history
• Gather trade confirmations and account statements
• Click here to check eligibility

Disclaimer: This shareholder alert is for informational purposes only and does not constitute legal advice. Consult a qualified attorney for personalized guidance. No specific outcomes are guaranteed.